Shezad Malik MD JD

Invokana linked to serious side effects

Invokana linked to serious side effects. According to many medical experts, Invokana medication is linked to severe and life-threatening side effects including kidney failure, leg amputations, heart attacks and diabetic ketoacidosis. What is Invokana? Invokana (canagliflozin) was the first member […]

Craig Kelley

Diabetes Drug Invokana and Amputation Risk

The U.S. Food and Drug Administration (FDA) informed manufacturing giant Johnson & Johnson in May, 2017 that they must put new warning labels on diabetes drug, Invokana (generic, canagliflozin), and its variations, Invokamet and Invokamet XR.  The new warning is […]

Craig Kelley

There Could be Lead in Your Baby’s Food

A report recently conducted by the  Environmental Defense Fund, a not for profit, nonpartisan advocacy group, shows that twenty percent of baby food samples taken in their studies were positive for lead that is higher than the incidence of lead […]

Craig Kelley

Mibelas Nationwide Birth Control Recall

Lupin Pharmaceuticals, Inc. has voluntarily recalled some of its birth control pills, called Mibelas 24 Fe (Lot L600518, Expiration Date 05/18).  A packaging error occurred, in at least one market reported complaint, in which the blister pack the pills are […]

Matthew Sill

$2.4 billion global settlement to resolve thousands of lawsuits claiming diabetes drug Actos® causes bladder cancer.

The diabetes drug Actos (pioglitazone) has been used by thousands of Americans with many later suffering from bladder cancer.  The manufacturer of Actos, Takeda Pharmaceuticals, agreed to a $2.4 billion global settlement to resolve thousands of lawsuits from patients and […]

Jamie Sheller

Abbott Labs Hit With $15M Verdict In Depakote Trial

An Illinois federal jury found that Abbott Labs failed to properly warn doctors about the risk of a severe birth defect in the babies of women taking its blockbuster drug Depakote awarding a 10-year-old boy born with spina bifida $15 million. His […]

Kendra Goldhirsch

North Carolina Plaintiff Joins Xarelto MDL

On May 3, 2017, a North Carolina woman filed a new Xarelto lawsuit against manufacturers Janssen Pharmaceuticals, parent company Johnson & Johnson, and Bayer AG. She joined the current Xarelto MDL underway in the Eastern District of Louisiana, where the […]

Kendra Goldhirsch

ISMP Warns About Risks of Combining Aspirin with Xarelto

As parties prepare for the second Xarelto bellwether trial in the Xarelto Multidistrict Litigation (MDL)in the Eastern District of Louisiana, the Institute of Safe Medication Practices (ISMP) has released their QuarterWatch report for the third quarter of 2016. Among the […]

Roopal Luhana

First AndroGel Bellwether Trial Set to Begin

The long-anticipated AndroGel bellwether trial is scheduled to begin on June 5, 2017. The case is the first to go to trial in the multidistrict litigation (MDL), which was established in June 2014, in the Northern District of Illinois. That […]

Derek T. Braslow

Invokana Called into Question with Latest FDA Warning

When Invokana was first approved by the Food and Drug Administration (FDA) in 2013, it commenced a new class of diabetes treatment. Specifically known as an SGLT2 inhibitor, canagliflozin—the trade name of Janssen Pharmaceuticals’ Invokana—was the first drug of its […]